Found 16 matching trials
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine PHASE3 The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Show More Location
Teva Investigational Site 14742
Learn More & Join Trial
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH) PHASE3 The purpose of the current study is to evaluate the efficacy and safety of ...
Show More Location
Teva Investigational Site 13834
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder PHASE4 The primary objective is to evaluate the efficacy of monthly 225 mg sc frem...
Show More Location
Teva Investigational Site 14330
Learn More & Join Trial
Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine PHASE2 To evaluate the efficacy and safety of subcutaneous (SC) administration of ...
Show More Location
Saitama Medical University Hospital
Learn More & Join Trial
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine PHASE3 The study is being conducted to evaluate two doses of TEV-48125 in adult pa...
Show More Location
Teva Investigational Site 13628
Learn More & Join Trial
A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache PHASE3 This is a 68-week study to evaluate the long-term safety and efficacy of fr...
Show More Location
Teva Investigational Site 13834
Learn More & Join Trial
Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine PHASE3 To evaluate the long-term safety and tolerability of subcutaneous (SC) admi...
Show More Location
Saitama Medical University Hospital
Learn More & Join Trial
Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine PHASE3 The study is being conducted to evaluate two doses of TEV-48125 in adult pa...
Show More Location
Teva Investigational Site 13628
Learn More & Join Trial
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine PHASE3 Primary Objective:
To demonstrate the efficacy of fremanezumab administere...
Show More Location
Teva Investigational Site 88028
Learn More & Join Trial
A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients PHASE3 This trial assesses the safety of TEV-48125 when subcutaneously self-admini...
Show More Location
Sendai Zutsu No-Shinkei Clinic
Learn More & Join Trial